KRAS and colonic neoplasm: These studies will load drugs (curcumin, chemotherapeutic drugs, miR124, and KRAS siRNA) and deliver them to diseases (colon cancer, malignant pleural effusion, acute ischemic stroke, and metastatic pancreatic cancer) [102,103,104,105].